贝瑞基因
(000710)
| 流通市值：24.30亿 | | | 总市值：28.64亿 |
| 流通股本：3.00亿 | | | 总股本：3.54亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 246,677,815.54 | 338,151,330.53 | 286,653,283.75 | 326,046,775.72 |
| 结算备付金 | 0 | 0 | - | - |
| 拆出资金 | 0 | 0 | - | - |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 897,716,798.46 | 815,208,041.91 | 1,071,368,740.14 | 1,070,137,834.99 |
| 其中：应收票据 | 9,126,720 | 7,257,600 | 10,886,400 | 11,586,850 |
| 应收账款 | 888,590,078.46 | 807,950,441.91 | 1,060,482,340.14 | 1,058,550,984.99 |
| 应收款项融资 | 0 | 0 | - | - |
| 预付款项 | 10,752,214.14 | 8,279,682.68 | 27,620,978.95 | 30,174,468.71 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 5,100,313.7 | 4,973,294.75 | 5,770,910.83 | 5,404,644.55 |
| 其中:应收利息 | - | 0 | - | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 204,820,105.11 | 229,302,829.83 | 224,744,278.44 | 249,771,666.84 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 0 | 0 | - | - |
| 其他流动资产 | 66,022,192.05 | 63,224,956.08 | 57,373,018.2 | 52,906,599.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,442,724,961.38 | 1,472,996,759.37 | 1,678,036,453.32 | 1,738,947,233.18 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | - |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 0 | 0 | - | - |
| 长期股权投资 | 43,452,734.19 | 44,446,022.55 | 77,139,815.58 | 83,577,214.06 |
| 其他权益工具投资 | 0 | 0 | - | - |
| 其他非流动金融资产 | 4,007,939.39 | 4,000,991.17 | 8,903,091.86 | 16,274,526.85 |
| 投资性房地产 | 0 | 0 | - | - |
| 固定资产 | 659,768,917.71 | 676,808,155.99 | 771,075,541.21 | 770,866,270.16 |
| 在建工程 | 235,280,547.01 | 230,802,870.8 | 301,001,160.18 | 290,953,141.69 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 13,557,897.44 | 15,805,517.12 | 12,974,819.48 | 15,028,869.55 |
| 无形资产 | 47,550,105.37 | 49,670,552.88 | 49,808,869.82 | 49,871,514.07 |
| 开发支出 | 45,632,395.04 | 40,859,369.12 | 39,439,164.66 | 33,611,825.56 |
| 商誉 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 |
| 长期待摊费用 | 10,210,332.04 | 7,578,846.5 | 8,568,344.94 | 9,726,525.18 |
| 递延所得税资产 | 153,530,512.4 | 151,268,961.51 | 103,459,564.37 | 103,471,345.68 |
| 其他非流动资产 | 30,107,692.48 | 33,493,461.76 | 26,664,934.04 | 26,664,934.04 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,256,532,711.64 | 1,268,168,387.97 | 1,412,468,944.71 | 1,413,479,805.41 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,699,257,673.02 | 2,741,165,147.34 | 3,090,505,398.03 | 3,152,427,038.59 |
| 流动负债: | | | | |
| 短期借款 | 164,774,145.97 | 202,637,334.67 | 232,389,105.61 | 248,561,428.71 |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 278,768,604.44 | 292,484,114.6 | 290,247,580.65 | 304,410,114.8 |
| 其中：应付票据 | 15,505,406.31 | 15,505,406.31 | - | - |
| 应付账款 | 263,263,198.13 | 276,978,708.29 | 290,247,580.65 | 304,410,114.8 |
| 预收款项 | 0 | 0 | - | - |
| 合同负债 | 127,814,231.18 | 110,753,277.08 | 121,705,948.44 | 122,405,803.33 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 42,160,628.59 | 51,230,318.68 | 40,083,996.64 | 39,068,197.77 |
| 应交税费 | 19,445,287.5 | 25,370,484.7 | 28,046,788.74 | 17,892,293.62 |
| 其他应付款合计 | 15,375,832.32 | 16,025,718.43 | 17,646,454.76 | 16,836,106.68 |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 54,098,761.82 | 55,255,298.91 | 9,583,577.87 | 9,736,812.79 |
| 其他流动负债 | 10,593,116.53 | 9,335,255.42 | 9,929,236.28 | 10,231,928.26 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 713,030,608.35 | 763,091,802.49 | 749,632,688.99 | 769,142,685.96 |
| 非流动负债: | | | | |
| 长期借款 | 42,183,109.01 | 42,183,109.01 | 105,457,793.6 | 105,457,793.6 |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 2,433,650.78 | 3,503,280.14 | 4,356,721.54 | 6,590,835.64 |
| 长期应付款 | 0 | 0 | - | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 10,822,000 | 11,019,500 | 11,245,750 | 11,542,000 |
| 递延所得税负债 | 26,716,652.92 | 26,766,231.72 | 20,274,504.43 | 20,324,505.25 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 82,155,412.71 | 83,472,120.87 | 141,334,769.57 | 143,915,134.49 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 795,186,021.06 | 846,563,923.36 | 890,967,458.56 | 913,057,820.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 353,521,465 | 353,521,465 | 354,605,865 | 354,605,865 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 1,156,192,042.36 | 1,156,192,042.36 | 1,210,890,442.62 | 1,210,890,442.62 |
| 减:库存股 | 0 | 0 | 44,519,514.13 | 44,519,514.13 |
| 其他综合收益 | 16,552,727.14 | 16,501,304.02 | 17,661,732.83 | 18,144,350.04 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | 265,206,000.54 | 256,970,877.59 | 549,210,464.16 | 589,059,626.5 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,872,321,592.86 | 1,864,035,046.79 | 2,168,698,348.3 | 2,209,030,127.85 |
| 少数股东权益 | 31,750,059.1 | 30,566,177.19 | 30,839,591.17 | 30,339,090.29 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,904,071,651.96 | 1,894,601,223.98 | 2,199,537,939.47 | 2,239,369,218.14 |
| 负债和股东权益合计 | 2,699,257,673.02 | 2,741,165,147.34 | 3,090,505,398.03 | 3,152,427,038.59 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-28 | 2023-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |